Astana Biomed Group, an authorized Abcam distributor in Central Asia

Alzheimer's disease

Human MAPK3 (ERK1) knockout A-431 cell line (ab276077)

Description:
MAPK3 KO A-431 cell line
Application:
Reactivity:
Conjugate:

Human MAPT knockout SHSY-5Y cell line (ab280077)

Description:
Human MAPT knockout SHSY-5Y cell line
Application:
Reactivity:
Conjugate:

Human MAPT knockout U-87 MG cell line (ab269490)

Description:
Human MAPT knockout U-87 MG cell line
Application:
Reactivity:
Conjugate:

Leupeptin hemisulfate, serine/cysteine protease inhibitor (ab141404)

Description:
Reversible competitive serine/cysteine protease inhibitor
Application:
Reactivity:
Conjugate:

Limonin, Limonoid (ab141949)

Description:
Limonoid with antiviral activity
Application:
Reactivity:
Conjugate:

LY2886721, BACE-1 inhibitor (ab223886)

Description:
Potent and selective BACE-1 inhibitor
Application:
Reactivity:
Conjugate:

MK-8931, Beta-sectetase inhibitor (ab223883)

Description:
Selective, potent Beta-sectetase inhibitor
Application:
Reactivity:
Conjugate:

Nafamostat Mesylate, Protease inhibitor (ab141432)

Description:
Broad spectrum, potent protease inhibitor
Application:
Reactivity:
Conjugate:

Niflumic acid, Anion channel blocker NSAID (ab142925)

Description:
A NSAID and potent anion channel blocker
Application:
Reactivity:
Conjugate:

NPPB, chloride channel blocker (ab141521)

Description:
Potent chloride channel blocker
Application:
Reactivity:
Conjugate:
© 2021 Astana Biomed Group LLP. All rights reserved.